Market Place
Sourcing Support
Cellares, Cabaletta Bio Sign 10-Year Deal to Scale Rese-cel
28 Apr 2026 //
BUSINESSWIRE
Cabaletta Bio, Cellares Ink 10-Year Supply Deal For Rese-Cel
28 Apr 2026 //
GLOBENEWSWIRE
Cabaletta Bio Doses First Patients with Rese-cel from Cellares
14 Apr 2026 //
PHARMIWEB
Cabaletta Bio Joins TD Cowen Health Care Conference
24 Feb 2026 //
GLOBENEWSWIRE
Cabaletta Bio Joins Guggenheim Biotech Summit 2026
05 Feb 2026 //
GLOBENEWSWIRE
Cabaletta Bio Clears IND Amendment For Rese-Cel Manufacturing
12 Jan 2026 //
PHARMIWEB
Cabaletta Bio Announces 2026 Strategic Priorities
12 Jan 2026 //
GLOBENEWSWIRE
Cabaletta Bio Reveals Q3 2025 Financials And Business Updates
10 Nov 2025 //
GLOBENEWSWIRE
Cabaletta Bio To Join Investor Conferences In Nov. & Dec
04 Nov 2025 //
GLOBENEWSWIRE
BMS, Cabaletta`s CAR T Therapy Shows Promise In Small Lupus Study
28 Oct 2025 //
BIOSPACE
Cabaletta Bio Unveils Positive Rese-Cel Data At ACR Convergence
27 Oct 2025 //
GLOBENEWSWIRE
Cabaletta Corrals Cell Therapy Legend—Chutes & Ladders
17 Oct 2025 //
FIERCE BIOTECH
Cabaletta Picks Up The Pace With New CCO From Legend, Celgene
14 Oct 2025 //
FIERCE PHARMA
Cabaletta`s CAR-T Wipes Out B Cells With No Preconditioning
10 Oct 2025 //
FIERCE BIOTECH
Cabaletta Bio Unveils Rese-Cel Data Showing Biologic Activity
09 Oct 2025 //
GLOBENEWSWIRE
Cabaletta Bio to Present at September Investor Conferences
27 Aug 2025 //
GLOBENEWSWIRE
Cabaletta Bio Reports Q2 2025 Financials, Updates on Business
07 Aug 2025 //
GLOBENEWSWIRE
Cabaletta Bio Reports Clinical Wins in Multiple Diseases
12 Jun 2025 //
PRESS RELEASE
Cabaletta Bio Announces Pricing of Public Offering of Securities
11 Jun 2025 //
GLOBENEWSWIRE
Cabaletta Bio at Jefferies Global Healthcare Conference
29 May 2025 //
GLOBENEWSWIRE
Cabaletta Plans 2027 Rese-cel BLA in Myositis After FDA Alignment
15 May 2025 //
GLOBENEWSWIRE
Patient suffers side effect in Cabaletta CAR-T trial
02 Apr 2025 //
FIERCE BIOTECH
Cellares, Cabaletta Bio Complete Rese-cel Manufacturing Program
19 Mar 2025 //
BUSINESSWIRE
Cabaletta Bio Shows Deepening Clinical Responses For Rese-Cel
18 Feb 2025 //
GLOBENEWSWIRE
Cabaletta Bio Updates Clinical Data on Rese-cel at Meetings
18 Feb 2025 //
GLOBENEWSWIRE
Cabaletta Bio To Present Rese-cel Clinical Data In Feb Meetings
11 Feb 2025 //
GLOBENEWSWIRE
Cabaletta to Participate in Guggenheim SMID Cap Biotech Conference
29 Jan 2025 //
GLOBENEWSWIRE
Cabaletta Bio Outlines Strategic Priorities & Milestones for 2025
13 Jan 2025 //
GLOBENEWSWIRE
Cabaletta Bio to Attend December Investor Conferences
26 Nov 2024 //
GLOBENEWSWIRE
Cabaletta Bio Presents Positive CABA-201 Safety & Efficacy at ACR
18 Nov 2024 //
GLOBENEWSWIRE
Cabaletta Bio Reports Q3 2024 Financial & Business Update
14 Nov 2024 //
GLOBENEWSWIRE
Cabaletta Bio to Attend Guggenheim Healthcare Innovation Conference
06 Nov 2024 //
GLOBENEWSWIRE
Cabaletta Bio To Present CABA-201 Data At ACR Convergence
25 Sep 2024 //
GLOBENEWSWIRE
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
28 Aug 2024 //
GLOBENEWSWIRE
Cabaletta Bio Reports Q2 2024 Results And Provides Business Update
08 Aug 2024 //
GLOBENEWSWIRE
Additional drugmakers flag risks working with WuXi amid heightened US scrutiny
02 Apr 2024 //
ENDPTS
Cabaletta Bio Receives Additional FDA Fast Track Designations for CABA-201
08 Jan 2024 //
GLOBENEWSWIRE
Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application
06 Nov 2023 //
GLOBENEWSWIRE
Cabaletta Bio Receives FDA Clearance of IND Application with CABA-201
02 Oct 2023 //
GLOBENEWSWIRE
Cabaletta Bio and WuXi Announce Expansion of GMP Agreement to Include CABA-201
22 Aug 2023 //
GLOBENEWSWIRE
Cabaletta Bio Announces Proposed Public Offering of Common Stock
17 May 2023 //
GLOBENEWSWIRE
Cabaletta Bio Announces Pricing of Public Offering of Common Stock
17 May 2023 //
GLOBENEWSWIRE
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201
16 May 2023 //
PRESS RELEASE
Cabaletta Bio to Present at the American Society of Gene and Cell Therapy
02 May 2023 //
GLOBENEWSWIRE
Cabaletta’s CAR-T therapy for lupus earns key FDA designation
01 May 2023 //
CIINICAL TRIALS ARENA
Cabaletta Bio Receives FDA Fast Track Designation for CABA-201
01 May 2023 //
GLOBENEWSWIRE
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201
31 Mar 2023 //
GLOBENEWSWIRE
